Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Alice Weaver

Concepts (117)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
6
2025
617
1.600
Why?
Human papillomavirus 16
2
2024
35
1.360
Why?
Papillomavirus Infections
3
2025
330
1.220
Why?
Career Choice
3
2022
215
1.050
Why?
Carcinoma, Squamous Cell
5
2017
683
0.880
Why?
Salivary Gland Neoplasms
1
2023
41
0.790
Why?
Personnel Selection
1
2019
78
0.600
Why?
CD8-Positive T-Lymphocytes
1
2024
916
0.560
Why?
Students, Medical
2
2019
339
0.550
Why?
Fibroblast Growth Factor 1
1
2016
12
0.520
Why?
Education, Medical, Graduate
2
2022
476
0.500
Why?
Receptor, Notch1
1
2016
64
0.500
Why?
Oropharyngeal Neoplasms
1
2016
62
0.500
Why?
Schools, Medical
1
2017
145
0.490
Why?
Poly(ADP-ribose) Polymerases
1
2015
99
0.470
Why?
Mouth Neoplasms
1
2016
120
0.470
Why?
DNA Breaks, Double-Stranded
1
2015
42
0.470
Why?
Calcium-Binding Proteins
1
2016
218
0.470
Why?
Biomedical Research
2
2022
688
0.460
Why?
Robotic Surgical Procedures
1
2016
126
0.450
Why?
DNA Repair
2
2015
229
0.450
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2015
116
0.430
Why?
Communication
1
2019
872
0.420
Why?
Papillomaviridae
2
2025
125
0.350
Why?
Curriculum
1
2017
978
0.330
Why?
Neoplasm Recurrence, Local
1
2016
1057
0.330
Why?
Internship and Residency
1
2019
1131
0.310
Why?
Papillomavirus E7 Proteins
1
2024
11
0.220
Why?
Oncogene Proteins, Viral
1
2024
22
0.220
Why?
Gene Fusion
1
2023
27
0.200
Why?
Salivary Glands
1
2023
33
0.200
Why?
Survival Analysis
2
2016
1320
0.200
Why?
Cell Culture Techniques
1
2025
363
0.200
Why?
Cancer Vaccines
1
2024
173
0.200
Why?
Lymphocytes, Tumor-Infiltrating
1
2024
209
0.190
Why?
Intracellular Signaling Peptides and Proteins
2
2015
455
0.190
Why?
B7-H1 Antigen
1
2023
218
0.180
Why?
Leukocytes, Mononuclear
1
2024
557
0.180
Why?
Physicians
2
2022
902
0.170
Why?
Repressor Proteins
1
2024
424
0.170
Why?
Mice, Inbred NOD
2
2023
601
0.150
Why?
Immunotherapy
1
2023
645
0.140
Why?
Cell Line, Tumor
4
2025
3396
0.140
Why?
Prognosis
2
2016
4011
0.140
Why?
Alabama
1
2017
34
0.140
Why?
Humans
12
2025
136899
0.130
Why?
Female
7
2024
72703
0.130
Why?
Cetuximab
1
2017
95
0.130
Why?
Pyrazines
1
2017
92
0.120
Why?
Biopsy, Needle
1
2016
191
0.120
Why?
Comet Assay
1
2015
16
0.120
Why?
Tumor Suppressor p53-Binding Protein 1
1
2015
13
0.120
Why?
Homologous Recombination
1
2015
25
0.120
Why?
Statistics, Nonparametric
1
2016
434
0.120
Why?
Chemoradiotherapy
1
2017
225
0.120
Why?
BRCA1 Protein
1
2015
76
0.120
Why?
Chromosomes
1
2015
108
0.120
Why?
Neoplasm Transplantation
1
2015
256
0.120
Why?
Disease-Free Survival
1
2016
690
0.110
Why?
Mice, SCID
1
2015
367
0.110
Why?
Neoplasm Invasiveness
1
2016
510
0.110
Why?
Benzimidazoles
1
2015
169
0.110
Why?
Middle Aged
4
2024
33118
0.110
Why?
DNA, Viral
1
2016
359
0.110
Why?
Universities
1
2017
431
0.110
Why?
Gene Expression Regulation, Neoplastic
2
2017
1400
0.100
Why?
Analysis of Variance
1
2016
1324
0.100
Why?
Pyrazoles
1
2017
422
0.100
Why?
Male
5
2024
67308
0.100
Why?
Signal Transduction
2
2016
5077
0.100
Why?
Immunohistochemistry
1
2016
1739
0.090
Why?
Aged
2
2024
23641
0.090
Why?
Logistic Models
1
2016
2060
0.090
Why?
Histones
1
2015
639
0.080
Why?
Neoplasms
1
2024
2655
0.080
Why?
Retrospective Studies
2
2017
15514
0.080
Why?
Membrane Proteins
1
2014
1167
0.070
Why?
Adult
2
2024
37595
0.070
Why?
Follow-Up Studies
1
2016
5126
0.070
Why?
Phenotype
1
2015
3201
0.070
Why?
Risk Assessment
1
2016
3432
0.070
Why?
Apoptosis
1
2015
2542
0.060
Why?
Mice
3
2023
17775
0.060
Why?
Cohort Studies
1
2016
5711
0.060
Why?
Cancer-Associated Fibroblasts
1
2025
20
0.060
Why?
Antineoplastic Agents
1
2017
2140
0.060
Why?
Coculture Techniques
1
2025
240
0.060
Why?
Surveys and Questionnaires
1
2017
5730
0.050
Why?
Treatment Outcome
1
2017
10768
0.050
Why?
Programmed Cell Death 1 Receptor
1
2023
251
0.050
Why?
Lung Neoplasms
1
2014
2490
0.050
Why?
Flow Cytometry
1
2025
1185
0.050
Why?
Animals
3
2023
36915
0.040
Why?
Personal Satisfaction
1
2022
210
0.040
Why?
Minority Groups
1
2022
269
0.040
Why?
United States
1
2016
14595
0.040
Why?
Checkpoint Kinase 2
1
2017
29
0.030
Why?
Checkpoint Kinase 1
1
2017
30
0.030
Why?
Drug Synergism
1
2017
379
0.030
Why?
Myristoylated Alanine-Rich C Kinase Substrate
1
2014
6
0.030
Why?
Tissue Array Analysis
1
2014
57
0.030
Why?
Molecular Mimicry
1
2014
40
0.030
Why?
Radiation, Ionizing
1
2014
81
0.030
Why?
Radiation Tolerance
1
2014
98
0.030
Why?
DNA Damage
1
2017
420
0.030
Why?
Xenograft Model Antitumor Assays
1
2017
857
0.030
Why?
Combined Modality Therapy
1
2017
1240
0.030
Why?
Cell Survival
1
2017
1122
0.030
Why?
Protein Structure, Tertiary
1
2014
869
0.020
Why?
Molecular Targeted Therapy
1
2014
413
0.020
Why?
Peptide Fragments
1
2014
707
0.020
Why?
Amino Acid Sequence
1
2014
2143
0.020
Why?
Phosphorylation
1
2014
1762
0.020
Why?
Molecular Sequence Data
1
2014
2901
0.020
Why?
Cell Proliferation
1
2017
2471
0.020
Why?
Adenocarcinoma
1
2014
934
0.020
Why?
Mutation
1
2014
3948
0.010
Why?
Weaver's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)